Rare diseases
Investigational molecules
Locations
Back to Austria841 clinical trials in Vienna, Austria across 10 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Study of Brenipatide (LY3537031) in Adults with Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
AustriaAustriaAustriaPhase 3 study of ZL-1310 versus topotecan hydrochloride in patients with relapsed small cell lung cancer
AustriaOrelabrutinib in Patients with Primary Progressive Multiple Sclerosis
AustriaA Phase III Study of Survodutide in Adults with Compensated NASH Cirrhosis to Assess Liver Outcomes and Safety
AustriaA Phase III trial of BI 456906 weekly injections in adults with NASH and stage 2‑3 liver fibrosis
AustriaStudy of sotorasib, panitumumab and a drug combination for patients with metastatic colorectal cancer with KRAS p.G12C mutation.
AustriaA study to evaluate the effectiveness and safety of duvakitug in patients with moderate to severe Crohn's disease
AustriaA study to evaluate the efficacy and safety of duvakitug in patients with moderate to severe Crohn's disease
AustriaPhase III Randomized Study of Rilvegostomig vs. Pembrolizumab with Platinum-based Chemotherapy in PD-L1 Expressing Metastatic Squamous NSCLC
AustriaA Study Comparing Empasiprubart Versus Intravenous Immunoglobulin in Adults With Chronic Inflammatory Demyelinating Polyneuropathy
AustriaThe busiest research cities in the country
What the registry says about research in the country
Clinical trials focusing on innovative treatments for various cancer types, including pancreatic ductal adenocarcinoma, gastric cancer, and non-small cell lung cancer. Studies evaluating new therapeutic approaches for breast cancer and multiple myeloma are also underway.
Research includes evaluation of novel drug combinations and immunotherapy approaches for improved patient outcomes.
Investigations into major depression and its treatment mechanisms, including studies on dopamine synthesis and antidepressant effectiveness. Research examines innovative therapeutic approaches using ketamine and other compounds.
Focus on understanding brain activation patterns and treatment responses in psychiatric conditions.
Research on plaque psoriasis, rheumatic diseases, and Sjögren's syndrome. Studies evaluate new biological therapies and treatment approaches for chronic inflammatory conditions.
Emphasis on developing targeted therapies for improved disease management and patient quality of life.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
